Kaleido Biosciences, Inc. Skyrocketed

Thu, Apr 14, 2022 at 05:30 PM
Kaleido Biosciences, Inc. Skyrocketed

Kaleido Biosciences, Inc. (KLDO:NASDAQ) jumped higher at $0.29, a gain of 68.6%. The stock appeared on our News Catalysts scanner on Mon, Mar 28, 2022 at 05:27 PM in the 'MISCELLANEOUS' category. From Wed, Mar 30, 2022, the stock recorded 20.00% Up Days and 9.09% Green Days

About Kaleido Biosciences, Inc. (KLDO:NASDAQ)

Kaleido Biosciences Inc is a clinical-stage healthcare company. It is focused on leveraging the potential of the microbiome organ to treat disease and improve human health. Its product candidates are Microbiome Metabolic Therapies, or MMTs, which are designed to modulate the metabolic output and profile of the microbiome.

Share
Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
monthly
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.